From System Design to Drug Design. The Rationale

From System Design to Drug Design. The Rationale
by Bernard Murphy on 05-22-2024 at 6:00 am

Drug development cycle min

I’m guessing that more than a few people were mystified (maybe still are) when Cadence acquired OpenEye Scientific, a company known for computational molecular design aimed at medical drug/therapeutics discovery. What could EDA, even SDA (system design automation), and drug discovery possibly have in common? More than you… Read More